Doxycycline Capsules Recalled for Temperature Control Deviation
McKesson Medical-Surgical is recalling Doxycycline Capsules, USP, 100 mg due to temperature abuse during manufacturing. The Class II recall affects 3 bottles distributed nationwide across the USA.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class II recall due to a manufacturing control deviation with no reported illnesses or injuries cited in the source. Per the severity rubric, Class II recalls without hospitalization reports score at most Moderate (2). The hazard is a manufacturing practice violation with potential but unconfirmed impact.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Doxycycline Capsules, USP, 100 mg in 50-count bottles (NDC 63304-616-50), distributed by Sun Pharmaceuticals. Approximately 3 bottles were affected and distributed nationwide across the USA.
The recall was issued due to a cGMP deviation: temperature abuse during manufacturing. Temperature control is essential for maintaining pharmaceutical product stability and efficacy.
Healthcare providers and pharmacists who have received affected product should verify their inventory using the distribution dates provided by McKesson. Patients currently taking this medication should contact their healthcare provider or pharmacist for guidance. The recalling firm is notifying all known consignees and will provide detailed lot number information to assist with recall completion.
The recalled product
- Product
- DOXYCYCLINE (DOXYCYCLINE)
- Brand
- DOXYCYCLINE
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Prescription Antibiotic
- Hazard
- temperature-abuse
- manufacturing-deviation
- stability-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
UPCs (1)
- 0363304614015
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · DOXYCYCLINE
- HighDoxycycline antibiotic tablets recalled for failed dissolution specifications
FDA (Drugs) · 2025-10-15
- ModerateDoxycycline Capsules Recalled Due to Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27